Patient presents with clinical features suggestive of Osteogenesis Imperfecta (OI), a genetic disorder characterized by brittle bones.  Assessment reveals a history of recurrent fractures, often with minimal trauma.  Physical exam findings may include blue sclerae, dentinogenesis imperfecta affecting teeth, hearing loss, and short stature.  Family history of OI may be present.  Differential diagnosis includes other skeletal dysplasias, child abuse, and rickets.  Diagnostic workup may include bone mineral density assessment, collagen studies, and genetic testing for COL1A1 and COL1A2 mutations to confirm the diagnosis and classify the specific OI type (e.g., Type I, Type II, Type III, Type IV).  Severity ranges from mild to severe, impacting prognosis and management strategies.  Treatment focuses on minimizing fracture risk, optimizing bone health, and maximizing functional independence.  Bisphosphonates are often prescribed to increase bone density and reduce fracture incidence.  Physical therapy, occupational therapy, and orthopedic interventions, such as rodding surgery, may be necessary to improve mobility and prevent deformities.  Genetic counseling is recommended for patients and families to discuss inheritance patterns and recurrence risks.  Patient education on safety precautions and lifestyle modifications is essential for long-term management.  Follow-up care includes regular monitoring of bone health, fracture management, and assessment of treatment efficacy.  ICD-10 code Q78.0 is typically used for coding Osteogenesis Imperfecta.